Laidlaw Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$994K Sell
10,202
-1,350
-12% -$135K 0.47% 45
2015
Q1
$1.16M Buy
11,552
+198
+2% +$20.1K 0.55% 44
2014
Q4
$1.19M Buy
11,354
+700
+7% +$73.8K 0.56% 43
2014
Q3
$1.14M Sell
10,654
-1,049
-9% -$109K 0.56% 43
2014
Q2
$1.22M Buy
11,703
+1,001
+9% +$101K 0.61% 43
2014
Q1
$1.05M Sell
10,702
-400
-4% -$37.1K 0.55% 43
2013
Q4
$1.02M Sell
11,102
-30
-0.3% -$2.77K 0.54% 45
2013
Q3
$965K Sell
11,132
-420
-4% -$37.7K 0.55% 46
2013
Q2
$992K Buy
+11,552
New +$980K 0.56% 45

Other funds holding JNJ

Laidlaw Group's JNJ Position: Q2 2015 in Review

Laidlaw Group reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2015, selling an estimated $135K and leaving 10,202 shares worth $994K. The position accounts for 0.47% of the portfolio, ranked #45.

Laidlaw Group first reported a position in JNJ in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.22M in Q2 2014. 2,105 funds tracked by Wall St. Rank hold JNJ as of Q2 2015.

  • Laidlaw Group held 10,202 shares of Johnson & Johnson worth $994K as of Q2 2015.
  • Laidlaw Group sold 1,350 Johnson & Johnson shares in Q2 2015, an estimated $135K.
  • Johnson & Johnson made up 0.47% of Laidlaw Group's portfolio in Q2 2015, its #45 holding.
  • Laidlaw Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 9 quarters since.
  • Laidlaw Group's Johnson & Johnson position peaked at $1.22M in Q2 2014.
  • 2,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2015.

Based on Laidlaw Group's 13F filing for Q2 2015, filed 31 Jul 2015.